شرکت «تمپوس» (Tempus) یه مجوز مشتی از سازمان غذا و داروی آمریکا (FDA) واسه نرم‌افزار هوش مصنوعی جدیدش به اسم Tempus ECG-PH گرفته

We have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Tempus ECG-PH (pulmonary hypertension), an AI-enabled software device that analyzes standard 12-lead electrocardiograms (ECGs) for signs associated with pulmonary hypertension. This is the third FDA-cleared device in our growing cardiovascular portfolio, expanding our suite of next-generation AI products aimed at identifying patients at risk for complex cardiac conditions. Learn more: https://tempus.co/4c2Z2hw